Bruce Duncan Samuel Allan

Title: Bruce Duncan Samuel Allan: Innovator in Glaucoma Treatment

Introduction

Bruce Duncan Samuel Allan is a notable inventor based in London, GB. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. His innovative approach has led to the development of a unique medical device aimed at improving patient outcomes.

Latest Patents

Bruce Duncan Samuel Allan holds a patent for a device designed for use in the eye. This glaucoma filtration implant features a generally tubular body section with an oblong external diameter formed of a continuous convex curve. The device incorporates a flow resistance structure within its internal lumen, which has a reduced diameter to regulate liquid flow. The flow resistance structure can measure up to 5000 µm in length and has a diameter ranging from 15 to 50 µm, specifically selected to achieve a pressure drop between 5 to 15 mm Hg. Additionally, the internal conduit for liquid flow may include a removable flow inhibitor, which can be eliminated post-implantation using an ophthalmic YAG laser. The device is constructed from biocompatible materials, ensuring safety and efficacy for patients.

Career Highlights

Bruce Duncan Samuel Allan is affiliated with University College London, where he continues to engage in research and development in the field of medical devices. His work has been instrumental in advancing techniques for glaucoma treatment, showcasing his commitment to improving healthcare solutions.

Collaborations

Some of his notable coworkers include Andrew Victor Graham Muir and Stephen A Jones. Their collaborative efforts contribute to the innovative research environment at University College London.

Conclusion

Bruce Duncan Samuel Allan's contributions to glaucoma treatment through his patented device exemplify the impact of innovation in healthcare. His work not only enhances patient care but also reflects the importance of collaboration in advancing medical technology.